ArticleOncotarget2017
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
Marco Fioramonti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it
ArticleOncotarget2017
Marco Fioramonti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.